Covid-19 is pushing pharma companies to the cloud
The Covid-19 pandemic has rapidly accelerated the drug industry’s migration to the cloud, with pharma striking new deals with tech giants.
The Covid-19 pandemic has rapidly accelerated the drug industry’s migration to the cloud, with pharma striking new deals with tech giants.
It’s widely known that exercise is beneficial for health — but why? A new study in rats offers insight.
Check out the latest edition of Adam’s Biotech Scorecard, a new newsletter from @statnews.
Extensive testing of pasteurized commercially purchased milk and other dairy products from 38 states found no evidence of live H5N1 bird flu virus.
A House subcommittee investigating the “lab leak” theory of Covid origins accuses EcoHealth of misrepresenting its virus research in Wuhan and pushes to deny it…
As national awareness of mental illness rises and innovative care models emerge, many advocates now see a rare opportunity to remake mental health crisis care…
BridgeBio Pharma is spinning out its oncology subsidiary into a fully independent company, as it concentrates its resources on an anticipated launch of its pivotal…
Novartis already produces the leading drug in the radiopharmaceutical field. Now, it is devoting even more attention to these cancer treatments with a new acquisition.
The new funding led by General Catalyst and 7wireVentures values Transcarent at $2.2 billion, will be used for AI projects, acquisitions.
Measures of biological age have exploded into health research and have fueled hype around consumer tests. But the field of aging has still not settled…
Scientists are frustrated that the USDA again failed to include basic information about H5N1 genetic sequences from cows when the data were released this week.